ITCI Annual ROE
-22.39%
+25.33%+53.08%
31 December 2023
Summary:
As of January 20, 2025, ITCI annual return on equity is -22.39%, with the most recent change of +25.33% (+53.08%) on December 31, 2023. During the last 3 years, it has risen by +30.91% (+57.99%). ITCI annual ROE is now at all-time high.ITCI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Quarterly ROE
-10.58%
+1.32%+11.09%
30 September 2024
Summary:
As of January 20, 2025, ITCI quarterly return on equity is -10.58%, with the most recent change of +1.32% (+11.09%) on September 30, 2024. Over the past year, it has increased by +13.83% (+56.66%). ITCI quarterly ROE is now -132.03% below its all-time high of 33.03%, reached on June 30, 2013.ITCI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.1% | +56.7% |
| 3 y3 years | +58.0% | +56.7% |
| 5 y5 years | +44.3% | +56.7% |
ITCI ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.6% | at high | +80.4% |
| 5 y | 5-year | at high | +61.1% | at high | +83.1% |
| alltime | all time | at high | +86.8% | -132.0% | +83.1% |
Intra-Cellular Therapies ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -10.58%(-11.1%) |
| June 2024 | - | -11.90%(-35.0%) |
| Mar 2024 | - | -18.32%(-19.1%) |
| Dec 2023 | -22.39%(-53.1%) | -22.65%(-7.2%) |
| Sept 2023 | - | -24.41%(-12.7%) |
| June 2023 | - | -27.95%(-14.7%) |
| Mar 2023 | - | -32.75%(-16.3%) |
| Dec 2022 | -47.72%(-9.7%) | -39.13%(-18.4%) |
| Sept 2022 | - | -47.98%(-11.2%) |
| June 2022 | - | -54.04%(+2.0%) |
| Mar 2022 | - | -53.00%(+1.7%) |
| Dec 2021 | -52.87%(-0.8%) | -52.09%(+21.4%) |
| Sept 2021 | - | -42.91%(+5.3%) |
| June 2021 | - | -40.76%(-2.2%) |
| Mar 2021 | - | -41.66%(-13.0%) |
| Dec 2020 | -53.30%(-7.5%) | -47.87%(-10.2%) |
| Sept 2020 | - | -53.29%(-15.0%) |
| June 2020 | - | -62.66%(+9.3%) |
| Mar 2020 | - | -57.34%(-0.2%) |
| Dec 2019 | -57.62%(+43.4%) | -57.48%(+12.2%) |
| Sept 2019 | - | -51.22%(+6.5%) |
| June 2019 | - | -48.08%(+10.4%) |
| Mar 2019 | - | -43.55%(+8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -40.18%(+70.5%) | -39.99%(+7.4%) |
| Sept 2018 | - | -37.24%(+14.0%) |
| June 2018 | - | -32.67%(+16.1%) |
| Mar 2018 | - | -28.13%(+6.0%) |
| Dec 2017 | -23.56%(-13.8%) | -26.54%(-0.2%) |
| Sept 2017 | - | -26.60%(-1.7%) |
| June 2017 | - | -27.05%(-6.0%) |
| Mar 2017 | - | -28.79%(+5.3%) |
| Dec 2016 | -27.34%(-22.2%) | -27.33%(+4.7%) |
| Sept 2016 | - | -26.10%(-10.1%) |
| June 2016 | - | -29.04%(-2.3%) |
| Mar 2016 | - | -29.71%(-13.6%) |
| Dec 2015 | -35.12%(-12.9%) | -34.37%(-10.8%) |
| Sept 2015 | - | -38.55%(-3.5%) |
| June 2015 | - | -39.93%(+25.0%) |
| Mar 2015 | - | -31.94%(+18.1%) |
| Dec 2014 | -40.34%(-76.3%) | -27.04%(+11.8%) |
| Sept 2014 | - | -24.18%(-22.6%) |
| June 2014 | - | -31.25%(-4.6%) |
| Mar 2014 | - | -32.74%(-40.1%) |
| Dec 2013 | -170.09% | -54.66%(+119.4%) |
| Sept 2013 | - | -24.91%(-175.4%) |
| June 2013 | - | 33.03% |
FAQ
- What is Intra-Cellular Therapies annual return on equity?
- What is the all time high annual ROE for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual ROE year-on-year change?
- What is Intra-Cellular Therapies quarterly return on equity?
- What is the all time high quarterly ROE for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly ROE year-on-year change?
What is Intra-Cellular Therapies annual return on equity?
The current annual ROE of ITCI is -22.39%
What is the all time high annual ROE for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual return on equity is -22.39%
What is Intra-Cellular Therapies annual ROE year-on-year change?
Over the past year, ITCI annual return on equity has changed by +25.33% (+53.08%)
What is Intra-Cellular Therapies quarterly return on equity?
The current quarterly ROE of ITCI is -10.58%
What is the all time high quarterly ROE for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly return on equity is 33.03%
What is Intra-Cellular Therapies quarterly ROE year-on-year change?
Over the past year, ITCI quarterly return on equity has changed by +13.83% (+56.66%)